Search alternatives:
therapeutic resistance » therapeutic research (Expand Search), therapeutic response (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
therapeutic resistance » therapeutic research (Expand Search), therapeutic response (Expand Search)
decrease therapeutic » increased therapeutic (Expand Search), degrader therapeutics (Expand Search), great therapeutic (Expand Search)
-
221
Biofilm mass after antibiotic treatment.
Published 2025“…Although the use of fluoroquinolones and tetracyclines in children, who are the most frequently infected population, is not preferred over macrolides due to potential side effects, this work shows that synergistic interactions among therapeutic agents provide potential clinical paths to substantially reducing or eradicating <i><i>M. pneumoniae</i></i> biofilms, thereby decreasing morbidity. …”
-
222
The raw data for building the graphs in this study.
Published 2025Subjects: “…epithelial electrical resistance…”
-
223
<i>T</i>. <i>spiralis</i> IIL ESP-induced apoptosis stained by Annexin V-AbFlour488/PI staining.
Published 2025Subjects: “…epithelial electrical resistance…”
-
224
Western blotting identification of expression level of pyroptosis protein Gasdermin D (GSDMD) in IIL ESP-treated Caco-2 cells.
Published 2025Subjects: “…epithelial electrical resistance…”
-
225
Apoptosis inhibitor impeded larval invasion of Caco-2 monolayer.
Published 2025Subjects: “…epithelial electrical resistance…”
-
226
Changes of mRNA and protein expression levels of apoptotic genes of Caco-2 cells treated with <i>T</i>. <i>spiralis</i> IIL ESP.
Published 2025Subjects: “…epithelial electrical resistance…”
-
227
<i>T</i>. <i>spiralis</i> IIL ESP reduced TJ protein expression and destroyed the integrity of Caco-2 monolayer.
Published 2025Subjects: “…epithelial electrical resistance…”
-
228
<i>T</i>. <i>spiralis</i> IIL ESP induced Caco-2 cell apoptosis stained by DAPI, Hoechst 33258 and TUNEL staining.
Published 2025Subjects: “…epithelial electrical resistance…”
-
229
<i>T</i>. <i>spiralis</i> IIL ESP effect on Caco-2 cell viability.
Published 2025Subjects: “…epithelial electrical resistance…”
-
230
Primer sequences of human gut tight junctions and apoptosis-related genes for qPCR.
Published 2025Subjects: “…epithelial electrical resistance…”
-
231
-
232
Data Sheet 1_Based on quorum sensing: reverse effect of traditional Chinese medicine on bacterial drug resistance mechanism.pdf
Published 2025“…Emerging evidence confirms the therapeutic potential of traditional Chinese medicine in combating antimicrobial resistance. …”
-
233
Data Sheet 1_Evaluation of Lactiplantibacillus plantarum CRS 33 to therapeutic effects on a murine model of Escherichia coli-induced endometritis.zip
Published 2025“…Further validation in dairy cows is warranted to confirm its therapeutic potential under practical conditions.</p>…”
-
234
Tanshinone I as a novel therapeutic agent targeting von Willebrand factor-binding protein to mitigate <i>Staphylococcus aureus</i> pathogenicity
Published 2024“…This study underscores the potential of tanshinone I as a therapeutic agent against <i>S. aureus</i> infections, offering a novel strategy to combat bacterial infections while decreasing the critical issue of antibiotic resistance.…”
-
235
Data Sheet 1_Immunometabolic alterations in type 2 diabetes mellitus revealed by single-cell RNA sequencing: insights into subtypes and therapeutic targets.csv
Published 2025“…Transcription factor (TF) activity was analyzed, and drug enrichment analysis was performed to identify potential therapeutic targets.</p>Results<p>In patients with T2DM, a marked increase in monocytes and a decrease in CD4+ T cells were observed, indicating immune dysregulation. …”
-
236
Data Sheet 4_Immunometabolic alterations in type 2 diabetes mellitus revealed by single-cell RNA sequencing: insights into subtypes and therapeutic targets.csv
Published 2025“…Transcription factor (TF) activity was analyzed, and drug enrichment analysis was performed to identify potential therapeutic targets.</p>Results<p>In patients with T2DM, a marked increase in monocytes and a decrease in CD4+ T cells were observed, indicating immune dysregulation. …”
-
237
Data Sheet 2_Immunometabolic alterations in type 2 diabetes mellitus revealed by single-cell RNA sequencing: insights into subtypes and therapeutic targets.csv
Published 2025“…Transcription factor (TF) activity was analyzed, and drug enrichment analysis was performed to identify potential therapeutic targets.</p>Results<p>In patients with T2DM, a marked increase in monocytes and a decrease in CD4+ T cells were observed, indicating immune dysregulation. …”
-
238
Data Sheet 3_Immunometabolic alterations in type 2 diabetes mellitus revealed by single-cell RNA sequencing: insights into subtypes and therapeutic targets.csv
Published 2025“…Transcription factor (TF) activity was analyzed, and drug enrichment analysis was performed to identify potential therapeutic targets.</p>Results<p>In patients with T2DM, a marked increase in monocytes and a decrease in CD4+ T cells were observed, indicating immune dysregulation. …”
-
239
Data Sheet 1_Combinations of posaconazole and tacrolimus are effective against infections with azole-resistant Aspergillus fumigatus.docx
Published 2025“…Moreover, this combination enhanced antifungal activity by 4- to 15-fold against biofilm formation of azole-sensitive strains, though no synergy was observed against azole-resistant biofilms. In vivo studies in Galleria mellonella confirmed a 2- to 7-fold decrease in fungal burden of both azole-sensitive and azole-resistant strains when combining posaconazole with tacrolimus, relative to posaconazole alone.…”
-
240
Image 1_Phage (cocktail)-antibiotic synergism: a new frontier in addressing Klebsiella pneumoniae resistance.tif
Published 2025“…<p>Phages, which play a crucial role in regulating bacterial populations and evolution, have gained renewed attention as potential therapeutic agents especially in the face of rising antimicrobial resistance, such as in Klebsiella pneumoniae– a MDR pathogen with significant clinical implications for immunocompromised individuals. …”